CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
209.3
1.51%
Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 15:25

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.9
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.021945 %
Charges from full value of position ($-4.17)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.021945%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000277 %
Charges from full value of position ($-0.05)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000277%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency SEK
Margin 5%
Stock exchange Sweden
Commission on trade 0%

*Information provided by Capital.com

Getinge AB ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 212.5
Open* 214.6
1-Year Change* -16.76%
Day's Range* 209.3 - 217.5
52 wk Range 174.20-275.20
Average Volume (10 days) 571.68K
Average Volume (3 months) 17.44M
Market Cap 55.71B
P/E Ratio 26.53
Shares Outstanding 272.37M
Revenue 30.42B
EPS 8.26
Dividend (Yield %) 1.93887
Beta 0.73
Next Earnings Date Feb 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 209.3 -5.7 -2.65% 215.0 217.7 209.1
Apr 11, 2024 212.5 1.2 0.57% 211.3 213.6 209.4
Apr 10, 2024 212.1 -4.9 -2.26% 217.0 219.0 211.0
Apr 9, 2024 216.3 0.1 0.05% 216.2 218.7 215.4
Apr 8, 2024 218.0 7.7 3.66% 210.3 218.1 210.3
Apr 5, 2024 209.9 0.5 0.24% 209.4 210.3 208.0
Apr 4, 2024 211.2 3.5 1.69% 207.7 211.4 206.8
Apr 3, 2024 208.6 0.9 0.43% 207.7 209.0 206.3
Apr 2, 2024 207.6 -5.7 -2.67% 213.3 216.3 206.4
Mar 28, 2024 214.5 -1.2 -0.56% 215.7 217.4 212.8
Mar 27, 2024 216.4 8.7 4.19% 207.7 217.5 207.7
Mar 26, 2024 209.8 -1.0 -0.47% 210.8 211.8 206.9
Mar 25, 2024 212.1 5.5 2.66% 206.6 215.4 206.6
Mar 22, 2024 208.1 2.9 1.41% 205.2 210.9 204.0
Mar 21, 2024 206.1 -1.9 -0.91% 208.0 208.9 203.1
Mar 20, 2024 205.9 -3.2 -1.53% 209.1 210.1 204.7
Mar 19, 2024 208.9 2.4 1.16% 206.5 209.5 206.5
Mar 18, 2024 207.7 -4.7 -2.21% 212.4 214.3 205.6
Mar 15, 2024 213.9 1.2 0.56% 212.7 216.4 211.6
Mar 14, 2024 213.7 1.0 0.47% 212.7 215.3 211.2

Getinge B Events

Time (UTC) Country Event
Monday, April 22, 2024

Time (UTC)

06:00

Country

SE

Event

Q1 2024 Getinge AB Earnings Release
Q1 2024 Getinge AB Earnings Release

Forecast

-

Previous

-

Time (UTC)

11:00

Country

SE

Event

Q1 2024 Getinge AB Earnings Call
Q1 2024 Getinge AB Earnings Call

Forecast

-

Previous

-

Time (UTC)

13:00

Country

SE

Event

Getinge AB Annual Shareholders Meeting
Getinge AB Annual Shareholders Meeting

Forecast

-

Previous

-
Tuesday, April 23, 2024

Time (UTC)

12:00

Country

SE

Event

Getinge AB
Getinge AB

Forecast

-

Previous

-

Time (UTC)

12:00

Country

SE

Event

Getinge AB
Getinge AB

Forecast

-

Previous

-
Thursday, July 18, 2024

Time (UTC)

06:00

Country

SE

Event

Q2 2024 Getinge AB Earnings Release
Q2 2024 Getinge AB Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 28292 27049 29819 26559 24172
Revenue 28292 27049 29819 26559 24172
Cost of Revenue, Total 14882 13469 15097 14104 13119
Gross Profit 13410 13580 14722 12455 11053
Total Operating Expense 24666 22678 25035 24187 24456
Selling/General/Admin. Expenses, Total 7484 6972 7596 7681 7312
Research & Development 1013 804 770 688 662
Depreciation / Amortization 1074 1002 1450 1247 1009
Unusual Expense (Income) 235 96 177 324 0
Other Operating Expenses, Total -44 335 -55 143 2354
Operating Income 3626 4371 4784 2372 -284
Interest Income (Expense), Net Non-Operating -131 -142 -257 -408 -309
Other, Net -23 -41 -42 -55 -31
Net Income Before Taxes 3472 4188 4485 1909 -624
Net Income After Taxes 2516 3001 3272 1256 -1132
Minority Interest -25 -31 -34 -34 -28
Net Income Before Extra. Items 2491 2970 3238 1222 -1160
Total Extraordinary Items 193
Net Income 2491 2970 3238 1222 -967
Income Available to Common Excl. Extra. Items 2491 2970 3239 1222 -1160
Income Available to Common Incl. Extra. Items 2491 2970 3239 1222 -967
Diluted Net Income 2491 2970 3239 1222 -967
Diluted Weighted Average Shares 272.37 272.37 272.37 272.37 272.37
Diluted EPS Excluding Extraordinary Items 9.14565 10.9043 11.8919 4.48655 -4.25892
Dividends per Share - Common Stock Primary Issue 4.25 4 3 1.5 1
Diluted Normalized EPS 11.5242 13.6509 14.5142 5.66778 -3.9797
Total Adjustments to Net Income 0 1
Interest Expense (Income) - Net Operating 22
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 7607 7176 7141 8499 6941
Revenue 7607 7176 7141 8499 6941
Cost of Revenue, Total 4016 4077 3622 4671 3561
Gross Profit 3591 3099 3519 3828 3380
Total Operating Expense 6292 6793 6240 7671 5834
Selling/General/Admin. Expenses, Total 2115 2140 2061 2013 1865
Research & Development 266 256 282 275 242
Depreciation / Amortization 253 245 245 367 245
Unusual Expense (Income) 108 60 20 202 14
Other Operating Expenses, Total -466 15 10 143 -93
Operating Income 1315 383 901 828 1107
Interest Income (Expense), Net Non-Operating -88 -78 -75 -47 -31
Other, Net -1
Net Income Before Taxes 1227 305 826 781 1075
Net Income After Taxes 901 217 593 561 805
Minority Interest -7 -2 -7 -5 -7
Net Income Before Extra. Items 894 215 586 556 798
Net Income 894 215 586 556 798
Income Available to Common Excl. Extra. Items 894 214 586 556 798
Income Available to Common Incl. Extra. Items 894 214 586 556 798
Diluted Net Income 894 214 586 556 798
Diluted Weighted Average Shares 272.37 272.37 272.37 272.37 272.37
Diluted EPS Excluding Extraordinary Items 3.2823 0.7857 2.15149 2.04134 2.92984
Dividends per Share - Common Stock Primary Issue 0 0 0 4.25 0
Diluted Normalized EPS 2.62447 0.95549 2.21211 3.178 2.96833
Total Adjustments to Net Income -1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 19106 15069 17431 14494 14148
Cash and Short Term Investments 5747 4078 6079 1266 1290
Cash & Equivalents 5676 4076 6056 1254 1273
Short Term Investments 71 2 23 12 17
Total Receivables, Net 6703 5941 6606 8212 7988
Accounts Receivable - Trade, Net 5954 5209 5854 7317 6969
Total Inventory 6232 4767 4513 4691 4544
Prepaid Expenses 423 283 233 325 326
Total Assets 52032 44555 45014 44713 43352
Property/Plant/Equipment, Total - Net 4868 4120 3973 4087 3160
Property/Plant/Equipment, Total - Gross 12079 10493 9274 9446 8223
Accumulated Depreciation, Total -7212 -6372 -5303 -5359 -5063
Goodwill, Net 22512 19681 17427 18674 18092
Intangibles, Net 4498 4467 4658 5609 6006
Long Term Investments 0 2 15 0
Note Receivable - Long Term 50 52 50 32 80
Other Long Term Assets, Total 998 1166 1473 1802 1866
Total Current Liabilities 11993 10610 9788 9864 10005
Accounts Payable 2252 1921 1446 1995 1868
Accrued Expenses 2348 2608 2699 2130 1960
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 793 811 2519 2952 3451
Other Current Liabilities, Total 6600 5270 3124 2787 2726
Total Liabilities 21994 19805 23990 24217 24151
Total Long Term Debt 5031 3495 7687 7068 7378
Long Term Debt 4100 2795 7020 6487 7378
Deferred Income Tax 1150 897 829 661 693
Minority Interest 415 427 462 477 454
Other Liabilities, Total 3405 4376 5224 6147 5621
Total Equity 30038 24750 21024 20496 19201
Common Stock 136 136 136 136 136
Additional Paid-In Capital 6789 6789 6789 6789 6789
Retained Earnings (Accumulated Deficit) 23113 17824 14099 13571 12276
Total Liabilities & Shareholders’ Equity 52032 44555 45014 44713 43352
Total Common Shares Outstanding 272.37 272.37 272.37 272.37 272.37
Capital Lease Obligations 931 700 667 581
Other Equity, Total 1
Other Current Assets, Total 1
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 19394 18390 17909 19106 17671
Cash and Short Term Investments 5337 4434 4625 5676 4839
Cash & Equivalents 5337 4434 4625 5676 4839
Total Receivables, Net 6820 6731 6497 7198 6366
Accounts Receivable - Trade, Net 4510 4537 4599 5275 4435
Total Inventory 7237 7225 6787 6232 6466
Total Assets 53540 52841 50985 52032 51907
Property/Plant/Equipment, Total - Net 5076 5176 4954 4868 4790
Intangibles, Net 27962 28259 27069 27010 28327
Long Term Investments 79 75 59 1048 1119
Total Current Liabilities 12342 11457 10388 11993 7821
Accounts Payable 2142 2139 2098 2252 1902
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2276 1468 868 793
Other Current Liabilities, Total 7924 7850 7422 8948 5919
Total Liabilities 21811 21833 20352 21994 21455
Total Long Term Debt 4538 5426 4948 5031 5499
Long Term Debt 3548 4390 3937 4100 4209
Capital Lease Obligations 990 1036 1011 931 1290
Minority Interest 287 296 426 415 455
Other Liabilities, Total 3206 3468 3369 3405 7680
Total Equity 31729 31008 30633 30038 30452
Common Stock 136 136 136 136 136
Additional Paid-In Capital 6789 6789 6789 6789 6789
Retained Earnings (Accumulated Deficit) 24804 24083 23707 23113 23527
Total Liabilities & Shareholders’ Equity 53540 52841 50985 52032 51907
Total Common Shares Outstanding 272.37 272.37 272.37 272.37 272.37
Other Long Term Assets, Total 1029 941 994
Deferred Income Tax 1438 1186 1221 1150
Other Equity, Total 1 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 3626 4371 4784 2372 -284
Cash From Operating Activities 3367 6560 7199 3832 2503
Cash From Operating Activities 2027 1814 2467 2223 1808
Non-Cash Items -31 126 -86 -121 1866
Cash Taxes Paid 1012 693 553 357 366
Cash Interest Paid
Changes in Working Capital -2255 249 34 -642 -887
Cash From Investing Activities -1470 -1329 -1991 -1117 -1339
Capital Expenditures -1136 -930 -1045 -1220 -1380
Other Investing Cash Flow Items, Total -334 -399 -946 103 41
Cash From Financing Activities -500 -7237 -297 -2772 -1440
Financing Cash Flow Items -16 -1 -17 3 -11
Total Cash Dividends Paid -1090 -858 -433 -298 -424
Issuance (Retirement) of Stock, Net 0
Issuance (Retirement) of Debt, Net 606 -6378 153 -2477 -1005
Foreign Exchange Effects 203 26 -110 38 23
Net Change in Cash 1600 -1980 4801 -19 -253
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 901 3626 2798 1691 780
Cash From Operating Activities -427 3367 2346 1070 647
Cash From Operating Activities 460 2027 1332 875 438
Non-Cash Items -116 -31 -161 -105 -58
Cash Taxes Paid 179 1012 711 578 268
Changes in Working Capital -1672 -2255 -1623 -1391 -513
Cash From Investing Activities -441 -1470 -1088 -551 -262
Capital Expenditures -291 -1136 -815 -539 -239
Other Investing Cash Flow Items, Total -150 -334 -273 -12 -23
Cash From Financing Activities -226 -500 -749 -604 -219
Financing Cash Flow Items -9 -16 -20 -1 -1
Total Cash Dividends Paid 0 -1090 -1089 -1089 0
Issuance (Retirement) of Debt, Net -217 606 360 486 -218
Foreign Exchange Effects 43 203 255 156 78
Net Change in Cash -1051 1600 764 71 244

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Getinge Company profile

About Getinge AB

Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, GetingeAB revenues decreased 9% to SEK27.05B. Net incomeapplicable to common stockholders decreased 8% to SEK2.97B.Revenues reflect a decrease in demand for the Company'sproducts and services due to unfavorable market conditions.Net income also reflects Research & Development Expenditure, Cap decrease of 19% to SEK346M (income), Acquisitionexpenses increase from SEK8M to SEK35M (expense).

Equity composition

April 2001: Bonus Issue, adjustment factor 0.9717.November 2003: Stock Split in the ratio 1:4. 02/2008,Rights Issue, 1 new share for every 16 shares held @ SEK120 (Factor: 1.014783). 11/2008, Rights Issue, 1 new sharefor every 9 shares held @ SEK 83.5 (Factor: 1.01930).

Industry: Medical Equipment

Lindholmspiren 7
P.O. Box 8861
GOETEBORG
VASTRA GOTALANDS 417 56
SE

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

ETH/USD

3,161.94 Price
+8.270% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

TSLA

172.44 Price
-0.890% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 0.13

XRP/USD

0.51 Price
+15.880% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

NVDA

880.87 Price
-2.750% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 0.42

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading